Stemson Therapeutics is driven by a vision where anyone battling the emotional trauma or social stigma of hair loss has an opportunity to truly cure their condition and safely restore their natural hair. Stemson was founded in 2018 based on a novel cell engineering process capable of producing the cell types required to regenerate hair follicles. Our engineered cells are combined with a unique tissue engineering solution and are capable of generating a net new supply of hair follicles for patients in need.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 09/16/20 | $7,500,000 | Seed |
Allergan Aesthetics Fortunis Capital | undisclosed |
